A master cancer gene hijacks a ‘molecular crowbar’ to make breast cancer cells invasive January 22, 2021
The price of a drug should be based on its therapeutic benefits – not just what the market will bear January 19, 2021
A master cancer gene hijacks a ‘molecular crowbar’ to make breast cancer cells invasive January 22, 2021
The price of a drug should be based on its therapeutic benefits – not just what the market will bear January 19, 2021
Conferences ASCO 2019: T-VEC shows improved survival over cytokine therapy in patients with melanoma June 4, 2019 Igor Puzanov, MD, Director of the Early Phase Clinical Trials Program and Chief of Melanoma…